Effects of Wearable Exoskeleton Robotic Gait Training in Subacute Stroke: A Pilot Randomized Controlled Trial

Viktas Aeternum Co., Ltd0 个研究点目标入组 28 人开始时间: 2023年10月31日最近更新: 2024年8月19日

适应症

试验速览

暂无简介。

•1.Patient aged 18 years or old
•2.First confirmed diagnosis of stroke through radiographs
•3.Hemiplegia
•4.Stroke occurred between 2 weeks and 6 months
•5.Functional Ambulation Categories ranging from 0 to 2
•6.Capable of independently deciding to participate in the study and able to follow instructions during assessment and gait training, as well as participate in controlling the wearable exoskeleton with the physiotherapist

•1.Patients with unstable vital signs or neurological symptoms
•2.Patients with medical diseases that may cause harm/adverse outcomes, such as uncontrolled hypertension (SBP > 180 mmHg or DBP > 100 mmHg), orthostatic hypotension, myocardial ischemia/heart failure in the last three months, respiratory disorders (such as chronic obstructive pulmonary disease and asthma), severe osteoporosis that increases the fractures risk from falling while walking and standing
•3.Patients with neurological disorders, such as Parkinson disease, dementia, and multiple sclerosis
•4.Patients with severe communication and cognitive impairment that prevent them from following instructions or participating in the training
•5.Patients with dermatitis or open wounds on the torso or lower limb
•6.Patients with lower limb length discrepancy greater than 2 cm
•7.Patients with a Modified Ashworth Scale of lower limb >= 3
•8.Patients with a limited range of motion in the lower limb that prevents them from changing from sitting to standing or stepping from standing with wearable exoskeleton robotic gait training

发起方

Viktas Aeternum Co., Ltd